Pulse nav.journalClub Debates activos Tendencias Explorar Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

© Synapse Social LLC, 2026

Política de privacidad

Evaluation of the doubling of production capacity for the Mumps API using roller bottles | Synapse

May 29, 2026Open Access

Evaluation of the doubling of production capacity for the Mumps API using roller bottles

Puntos clave

The aim is to evaluate the enhancement of mumps API production capacity using roller bottles.
Assessment of doubling production capacity
Utilization of roller bottle technology
Collaboration with Bio-Manguinhos for symposium presentation
Production enhancements demonstrated potential improvements in output and efficiency
Findings to be discussed at the International Symposium on Immunobiologicals

Resumen

Os autores externos submeteram sua publicação para apresentação de trabalho no evento 'International Symposium on Immunobiologicals', que foi coordenado e organizado pelo Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), da Fundação Oswaldo Cruz.

Leer artículo completoexternamente

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Santos et al. (Thu,) studied this question.

synapsesocial.com/papers/6a192c0ffab5b468c4415047 https://doi.org/https://doi.org/10.35259/isi.2026_76335

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Bio-Manguinhos and new generation of vaccines: consolidation of mRNA-LNP production and evaluation of critical quality attributes at pilot scale2026
2Scale-up of plasmid linearization for mRNA vaccine production: from development to pilot scale2026
3Method qualification for the assessment of mRNA vaccine encapsulation efficiency2026
4Analytical technology transfer for mRNA vaccine quality control2026
5Use of in-house strains in mandatory microbiological assays in the pharmaceutical industry and the importance of deposition in biological collections2026